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Abstract
Veterans who use Veterans Health Affairs (VHA) have the option of enrolling in and obtaining care from other non-VA 
sources. Dual system use may improve care by increasing options or it may result in poorer outcomes because of 
fragmented care. Our objective was to assess whether dual system use of VHA and Medicare for wound care was associated 
chronic wound healing. We conducted a retrospective cohort study of 227 Medicare-enrolled VHA users in the Pacific 
Northwest who had an incident, chronic lower limb wound between October 1, 2006 and September 30, 2007 identified 
through VHA chart review. All wounds were followed until resolution or for up to one year. Dual system wound care was 
identified through Medicare claims during follow-up. We used a proportional hazards model to compare wound healing 
among VHA-exclusive and dual wound care users, using a time-varying measure of dual use and treating amputation and 
death as competing risks. 18.1% of subjects were classified as dual wound care users during follow-up. After adjustment 
using propensity scores, dual use was associated with a significantly lower hazard of wound healing compared to VHA-
exclusive use (HR=0.63, 95%CI: 0.39-0.99, p=0.047). Hazards for the competing risks, amputation (HR=4.23,
95% CI: 1.61-11.15, p=0.003) and death (HR=3.08, 95%CI: 1.11-8.56, p=0.031), were significantly higher for dual users 
compared to VHA-exclusive users. Results were similar in inverse probability of treatment weighted analyses and in 
sensitivity analyses that excluded veterans enrolled in a Medicare managed care plan and that used a revised wound 
resolution date based on Medicare claims data, but were not always statistically significant. Overall, dual wound care use 
was associated with substantially poorer wound healing compared to VHA-exclusive wound care use. VHA may need to 
design programs or policies that support and improve care coordination for veterans needing chronic wound care.
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Abstract  
Veterans who use Veterans Health Affairs (VHA) have the option of enrolling in and obtaining 
care from other non-VA sources. Dual system use may improve care by increasing options or it 
may result in poorer outcomes because of fragmented care. Our objective was to assess 
whether dual system use of VHA and Medicare for wound care was associated chronic wound 
healing. We conducted a retrospective cohort study of 227 Medicare-enrolled VHA users in the 
Pacific Northwest who had an incident, chronic lower limb wound between October 1, 2006 
and September 30, 2007 identified through VHA chart review. All wounds were followed until 
resolution or for up to one year. Dual system wound care was identified through Medicare 
claims during follow-up. We used a proportional hazards model to compare wound healing 
among VHA-exclusive and dual wound care users, using a time-varying measure of dual use and 
treating amputation and death as competing risks. 18.1% of subjects were classified as dual 
wound care users during follow-up. After adjustment using propensity scores, dual use was 
associated with a significantly lower hazard of wound healing compared to VHA-exclusive use 
(HR=0.63, 95%CI: 0.39-0.99, p=0.047). Hazards for the competing risks, amputation (HR=4.23, 
95% CI: 1.61-11.15, p=0.003) and death (HR=3.08, 95%CI: 1.11-8.56, p=0.031), were significantly 
higher for dual users compared to VHA-exclusive users. Results were similar in inverse 
probability of treatment weighted analyses and in sensitivity analyses that excluded veterans 
enrolled in a Medicare managed care plan and that used a revised wound resolution date based 
on Medicare claims data, but were not always statistically significant. Overall, dual wound care 
use was associated with substantially poorer wound healing compared to VHA-exclusive wound 
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care use. VHA may need to design programs or policies that support and improve care 
coordination for veterans needing chronic wound care.  
 
Short running title:​ ​Dual system use and chronic wounds 
 
Key words:  ​chronic ulcers, wound healing, dual use, veterans  
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Introduction  
The Veterans Health Administration (VHA) is the largest integrated health system in the 
United States; in 2013, 8.9 million veterans were enrolled [1]. Among these VHA enrollees, 48% 
were dually enrolled in Medicare, including over 90% of VHA enrollees age 65 or older.​ ​An 
estimated 10% of all VHA enrollees [2,3] and up to half of Medicare-eligible veterans using 
outpatient VHA services​ ​[4] are dual Medicare-VHA users. Therefore, it is important to consider 
both VHA and Medicare systems when assessing health care utilization, health care quality, and 
health outcomes among veterans [5,6]. 
Prior research shows​ ​that some veterans use Medicare to augment their VHA care [7,8]. 
For some veterans, dual use of VHA and Medicare may improve health care outcomes by 
increasing treatment options. However, dual Medicare-VHA use is associated with service 
duplication, higher costs, and poorer outcomes [2,6,9,10].  Thus, dual use may result in poorer 
outcomes potentially due to lack of coordination of health care delivery [2,6,11]. 
An estimated 6.5 million US patients experience chronic wounds annually, and these 
wounds cause disability and reduce quality of life [12]. Chronic wounds typically occur on the 
lower limbs (LL) of people with at least one underlying chronic health condition, most 
commonly diabetes, venous disease, or arterial disease [13]. A coordinated treatment plan with 
a high level of guideline-concordant care improves the likelihood of wound healing and reduces 
the risk of amputation [14–16]. Given that the organization and delivery of health care 
influences chronic wound outcomes, these wounds present an informative case study for other 
health conditions and outcomes associated with dual system use. 
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The purpose of this study was to assess whether chronic wound healing differed 
between dual wound care users and VHA-exclusive wound care users among Medicare-enrolled 
veterans. We conceptualized dual health system use as veterans seeking chronic wound care 
from multiple health care providers and systems. Based on previous studies and the intensive 
health care management required for chronic wound healing, we hypothesized that dual use 
would be associated with poorer wound healing than VHA-exclusive use due to a reduction in 
consistency and coordination of care. Currently, little is known about how dual health system 
use impacts chronic wound care outcomes. Understanding whether greater fragmentation of 
wound care introduced through dual use will help inform appropriate follow-up care for 
veterans with chronic wounds. 
 
Methods  
Subject selection, study design, and data sources 
We included 227 veterans dually-enrolled in VHA and Medicare from a previous study of 
chronic wounds among rural and urban veterans in the Pacific Northwest. We identified 
potential subjects based on a set of 42 ICD-9 codes for LL wounds [17,18] then reviewed VHA 
chart notes to identify eligible subjects. Veterans were eligible for the study if they had an 
incident LL wound between October 1, 2006 and September 30, 2007 treated within VHA; a 
minimum wound duration of 30 days after first VHA treatment [19]; and at least two VHA 
wound treatment encounters, at least one of which was in an outpatient setting. The 
requirement of at least two encounters allowed us to track the wound outcome. The 
requirement of at least one outpatient visit was to limit our sample to veterans who were 
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healthy enough that wound healing was a reasonable expectation. We included each veteran’s 
first eligible wound.  
Baseline was the date of the first VHA wound care treatment encounter based on chart 
notes. Subjects were followed for up to one year after baseline or until the wound resolved. We 
used electronic medical record (chart) data from VHA to identify wounds and assess VHA 
treatment and wound outcomes. We used fee-for service claims to identify wound care in 
Medicare; chart notes were not available for Medicare-financed visits.​ ​The VA Puget Sound 
Health Care System’s Human Studies Subcommittee reviewed and approved this study (IRB 
#00253). 
 
Medicare eligibility  
We determined Medicare eligibility based on the Medicare denominator file in the 
calendar year of veterans’ baseline visits. We classified veterans as age-eligible (≥65 years) or 
disability-eligible (qualifying disability before age 65).  We excluded veterans whose original 
reason for Medicare eligibility was end-stage renal disease (ESRD; n=3) because they likely had 
different underlying health status and wound healing trajectories than veterans without ESRD.  
 
Dual VHA-Medicare use 
Our primary independent variable of interest was dual use of VHA and fee-for-service 
Medicare for wound care. We identified wound care encounters in Medicare using the same set 
of ICD-9 codes originally used to identify subjects. For outpatient care, we required that one of 
the following Evaluation and Management codes for a scheduled office visit or urgent care visit 
7 
 
was present in the carrier or outpatient claims along with the ICD-9 code: 99201-99205, 
99211-99215, 99241-99245, 99281-99285. For inpatient and long-term care, we included any 
hospital or skilled nursing claims that occurred within the study period and had at least one 
wound-related ICD-9 code. In order to appropriately classify the exposure (dual use of VHA and 
Medicare wound care), we identified the first date on which veterans had a Medicare claim 
with a wound-related ICD-9 code. Veterans were classified as dual users beginning with the 
time of their first Medicare visit and all times thereafter. 
 
Wound outcomes 
We used a competing risk outcome defined as the earliest event of the following: 
wound healing, amputation, death or end of follow-up. A wound was considered healed at the 
VHA encounter when a provider stated it had completely re-epithelialized (i.e., no open areas 
or scab remained). Amputations were identified through the VHA medical record via surgery 
reports and confirmed with Medicare claims, where applicable, using amputation surgery 
codes. We used information about the first amputation that removed the wound and classified 
amputations as minor (toe or transmetatarsal) or major (transtibial or transfemoral). Veteran 
deaths were identified using the date of death from the VA medical record and confirmed using 
the Medicare denominator file.  
 
Covariates and Adjustment 
We used several data sources to collect information on covariates. From the VHA 
electronic health record we recorded age, gender, marital status, zip code, service-connected 
8 
 
disability, comorbidity, and wound characteristics at baseline. From the Medicare denominator 
file, we recorded veterans’ race and ethnicity category and the original reason for Medicare 
eligibility. We used the Area Health Resource file for county-level information about the 
number of non-federal patient care physicians, the number of hospital beds, and population 
size in 2006. We used the “vincenty” command in Stata to calculate the distance from each 
veteran’s zip code center to the nearest VA facility based on latitude and longitude coordinates. 
In descriptive tables, we report age as under 65 or 65+, while in the analytic model we 
included it as a continuous variable. Likewise, we report race/ethnicity categories in more detail 
in the descriptive tables (white, black, Asian, Native American, Hispanic, other, or missing) than 
we included in the propensity score model (indicators only for white, non-Hispanic and black, 
non-Hispanic race/ethnicity.) We classified veterans as married or not married at baseline. We 
classified veterans as living in a rural residence using the VA classification system in place at the 
time of the study, which relied on the residential zip code and utilized United States Census 
Bureau-defined Urbanized Areas. We categorized veterans’ service-connected disability (SCD) 
rating as either below 50% (including not SCD eligible) and 50-100% to reflect priority status 
within VHA [20].  
We used VHA physician progress notes and the “Problem List” to determine whether 
veterans had any of the following thirteen chronic health conditions or events at baseline: 
diabetes, peripheral artery disease, hypertension, congestive heart failure, coronary artery 
disease, myocardial infarction, cerebrovascular disease, renal insufficiency or renal disease, 
liver disease, lower limb paralysis, connective tissue disease (e.g., rheumatoid arthritis, lupus), 
cancer, and HIV/AIDS. Veterans with higher comorbidity are more likely to use multiple health 
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care systems [6] and each of these conditions could be expected to influence wound healing 
[21–25]. To limit the number of covariates in our models, we counted the number of conditions 
a veteran had at baseline. We added one additional point if the veteran had a 
diabetes-associated complication (sensory neuropathy, renal disease, or retinopathy), similar to 
the Charlson-Deyo comorbidity index [26]. The maximum possible comorbidity score was 14. 
We also recorded whether or not veterans had ever had a lower limb wound or amputation 
before the study. 
For each wound, we classified the etiology based on ICD-9 diagnosis codes and VHA 
provider chart notes. We also recorded whether complex anatomy – e.g., Charcot foot or 
previous amputation – was present at the wound site at baseline. Finally, as a measure of 
wound severity at baseline we classified whether the wound had exposed bone, tendon, or 
joint or evidence of osteomyelitis (bone infection). 
 
Statistical analysis 
We used proportional hazards models with a time-varying measure of exposure (dual 
wound care use) to calculate hazard ratios (HR) for wound healing, accounting for the 
competing risks of amputation or death [27]. Time was defined as days of follow-up beginning 
30 days after baseline since all wounds had a minimum duration of 30 days by study definition. 
We used a competing risks approach because patients who undergo amputation to resolve 
their wound or who die with an active wound are likely to have had more severe wounds 
and/or underlying disease that result in the poorer outcome [22,23]; therefore, standard 
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approaches to estimating hazard ratios, like Cox proportional hazards regression, would be 
inappropriate since they assume that censoring is independent of the time to event.  
We compared dual users to VHA exclusive users, using a time-varying exposure such 
that veterans were classified as exposed (dual users) from the time of their first Medicare visits 
and at all times thereafter, accounting for multiple records per person, and adjusting for 
potential confounders using the propensity score and propensity score squared as the sole 
covariates in the competing risks models. We also used repeated all analyses using the IPTW 
weighted sample. An HR>1 indicates a higher rate of healing among dual users compared to 
VHA-exclusive users. We tested whether proportional hazards assumptions for the models 
were satisfied using Schoenfeld residual plots, and we used delta beta plots to identify 
influential subjects [28].  We plotted cumulative incidence curves to display overall time to 
healing for VHA-exclusive users and dual users, adjusted for covariates [29].  
We applied estimated propensity score adjustment to account for baseline differences 
across exposure groups [30,31]. We selected this approach because we were interested in 
adjusting for a broad range of covariates but had a relatively small sample size. We derived 
propensity scores by estimating a logistic regression model and generating the predicted 
probability of being a dual user as a function of the covariates described above. We based the 
model on existing literature [6,9,21–23] and included interactions between comorbidity score 
and wound etiology and between rural residence and each of the physician supply variables 
[32]. Once we estimated propensity scores, we also used them to calculate inverse probability 
of treatment weights (IPTW) for the sample, using the formula IPTW=(treatment/propensity 
score) + [(1-treatment)/(1-propensity score)], where treatment was equal to 1 for dual users 
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and 0 for VHA-exclusive users. [33]. We used the standardized difference, calculated using the 
Stata user-created command “pbalcheck,” to assess covariate balance in the original sample 
and in the samples weighted by propensity score and IPTW [33]. All analyses were conducted in 
Stata 13.1 (College Station, TX). 
 
Sensitivity Analyses 
We planned four sensitivity analyses ​a priori​. First, exclusively using VHA data to 
establish the wound resolution dates might result in bias among dual users. Specifically, a 
veteran who used Medicare wound care may have less VHA utilization and time to healing may 
be overestimated as a result. To address this issue, we estimated competing risk models after 
reassigning wound resolution dates for dual users based on the date of the last visit on which a 
wound-related claim (relevant ICD code) appeared in Medicare. The second sensitivity analysis 
excluded veterans who were enrolled in a Medicare managed care plans at any point during 
their wound episode. Visits paid for by a Medicare managed care plans do not appear as 
Medicare claims so including veterans enrolled in these plans might result in misclassification of 
veterans as VHA-exclusive users. Third, during the study period the Walla Walla VA Medical 
Center was participating in an intervention designed to improve wound care [17,18] and 
therefore may have provided different wound care than other sites, so we excluded veterans 
who received care at the Walla Walla VA Medical Center. Finally, we conducted sensitivity 
analyses in which we excluded VHA-exclusive subjects with estimated propensity scores that 
were outside the range of the dual users’ scores to assure the comparison groups were similar. 
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Results  
Veteran and wound characteristics  
Forty-one veterans (18.1%) were classified as dual wound care users at some time 
during follow-up and 186 were classified as VHA-exclusive wound care users throughout 
follow-up. The average age of both dual users and Medicare-eligible VHA-exclusive users at 
baseline was 69 years. The demographic, health, and zip-code based health supply 
characteristics of both groups of veterans were similar (Table 1). Nearly half of dual users and 
about one in three VHA-exclusive users had a previous LL wound that healed and 19% of dual 
users and 27% of VHA-exclusive users had a previous LL amputation. Wound etiology varied 
somewhat, with dual users more frequently having arterial wounds and VHA-exclusive users 
more frequently having diabetic and venous wounds. Weighting the sample by either the 
propensity score or IPTW general resulted in better balance across covariates, including wound 
etiology (Table 1). Dual users had higher estimated propensity scores, on average, than 
VHA-exclusive users (mean=0.33, SD=0.23 for dual users; mean=0.15, SD=0.13 for 
VHA-exclusive users). Estimated propensity scores ranged from 0.07-0.99 for dual users and 
0-0.55 for VHA-exclusive users. Likewise, IPTWs were higher for dual users, on average, than for 
VHA-exclusive users (mean=4.91, SD=3.67 for dual users; mean=1.21, SD=0.23 for 
VHA-exclusive users. IPTWs ranged from 1-13.88 for dual users and 1-2.22 for VHA-exclusive 
users.  
  
Wound outcomes 
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 During one year of follow up, 48.8% of dual users’ (n=20) and 77.9% (n=145) of 
VHA-exclusive users’ wounds healed, 14.6% (n=6) of dual users and 5.9% (n=11) of 
VHA-exclusive users underwent amputation, and 14.6% (n=6) of dual users and 5.9% (n=11) of 
VHA-exclusive users died with active wounds. The remaining 21.9% (n=9) of dual users’ and 
10.2% (n=19) VHA-exclusive users’ wounds were unresolved after one year of follow-up. In the 
unadjusted competing risks proportional hazards model, dual wound care use was associated 
with statistically significantly lower wound healing (HR=0.55, 95%CI: 0.35-0.85, p=0.007).  
After covariate adjustment using estimated propensity scores (PS), dual use was 
associated with significantly poorer wound healing compared to VHA-exclusive use (HR=0.63, 
95%CI: 0.39-0.99; Table 2). In the IPTW model, results were similar but not statistically 
significant (HR=0.65, 95%CI: 0.39-1.06). Figure 1 illustrates the lower cumulative incidence of 
wound healing among dual users than among VHA-exclusive users. The median time to healing 
from the baseline visit was 205 days (95%CI: 173-230) for dual users and 117 days (95%CI: 
104-129) for VHA-exclusive users. Dual users were significantly more likely than VHA-exclusive 
users to undergo amputation (PS-adjusted HR=4.23, 95%CI: 1.61-11.15,; IPTW HR=4.04, 95%CI: 
1.16-14.09)) or to die with an active wound (PS-adjusted HR=3.08, 95%CI: 1.11-8.56; IPTW 
HR=2.88, 95%CI: 0.80-10.29). Median time to amputation was 149 (95%CI: 36-319) days after 
baseline among dual users and 91 (95%CI: 39-272) days among VHA-exclusive users. Most 
amputations were minor, both among dual users (67%) and among VHA-exclusive users (64%). 
The median time to death was 154 (95%CI: 57-179) days after baseline among dual users and 
95 (95%CI: 71-225) days among VHA-exclusive users. 
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Sensitivity analyses 
In all four sensitivity analyses, the association between time-varying dual use and 
wound healing was similar to the main analysis. Point estimates for amputation and death were 
in the same direction (i.e., HRs>1), but varied across analyses and were not always statistically 
significant. We report results for the propensity-score adjusted models below; results from 
IPTW models were slightly attenuated in comparison and had wider confidence intervals and 
larger p-values. 
There were 14 (34.1%) dual users who had an earlier wound resolution date based on 
the Medicare record; differences ranged from 1 to 133 days. When we used these revised times 
to resolution, we found a stronger association between time-varying dual use and wound 
healing (HR=0.43, 95%CI: 0.26-0.70, p=0.001)but attenuated hazard ratios for amputation 
(HR=2.78, 95%CI: 1.04-7.28, p=0.041) and death ((HR=1.88, 95%CI: 0.62-5.75, p=0.27). 
Excluding veterans who were enrolled in Medicare managed care plans at any time during their 
wound episode (n=24 excluded; 1 (2.4%) dual user and 23 (12.4%) VHA-exclusive users) 
resulted in a similar HRs for wound healing(HR=0.60, 95%CI:0.38-0.96, p=0.032), amputation 
(HR=4.29, 95%CI: 1.60-11.45, p=0.04) and death(HR=3.34, 95%CI: 1.15-9.69, p=0.026). When 
we excluded veterans who received care at the Walla Walla VHA (n=17; 7 dual users (17.1%) 
and 10 (5.4%) VHA-exclusive users), the results were similar for wound healing(HR=0.63, 95%CI: 
0.39-1.01, p=0.055) and were attenuated for amputation (HR=2.42, 95%CI: 0.70-8.33, p=0.16) 
and death (HR=3.07, 95%CI: 1.08-8.70, p=0.035).  
When we restricted the analyses to veterans with estimated propensity scores ≥0.07 
(the lowest value for a dual user; n=58 VHA-exclusive users excluded), point estimates were 
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nearly the same as those in the main analysis for wound healing (HR=0.61, 95%CI: 0.38-0.97, 
p=0.035), but higher for amputation (HR=6.35, 95%CI: 2.14-18.91, p=0.001) and lower for death 
(HR=2.84, 95%CI: 1.02-7.91, p=0.045).  
 
Discussion  
Among patients with incident lower limb wounds, dual users of VHA and Medicare 
health services for follow-up wound care had significantly poorer wound healing relative to 
exclusive users of VHA follow-up wound care. This association was robust to adjustment for 
veteran demographic, health, and wound characteristics and to several sensitivity analyses. 
However, it was not statistically significant when we used IPTW methods for adjustment. We 
used a measure of dual use specific to wound care to isolate the effect of dual system 
utilization on wound healing and we restricted our regression analyses to Medicare-eligible 
veterans, for which all health service utilization within VHA and Medicare was likely to be 
observed. These findings are consistent with other studies that have found poorer outcomes 
among dual system users [2,10,34]: Helmer et al. found that Veterans with diabetes who used 
both VHA and Medicare had higher hemoglobin A1c levels compared to VHA-exclusive users, 
indicating poorer glycemic control for dual users [10]. Most veterans in this study had diabetes, 
and this poor control could have contributed to poorer wound outcomes. Veterans exclusively 
using VHA health services benefit from elements of an integrated health care system including 
an electronic health record accessible to all providers in the system. Our results suggest that 
veterans who choose to receive follow-up wound care from VHA and other non-VA sources 
exhibit worse wound healing outcomes potentially resulting from worse coordination of care. 
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Although not a primary outcome in this study, we found higher levels of outpatient 
wound care for dual users (average 11 visits per dual user compared to 7.5 per VHA-exclusive 
user), consistent with previous studies of dual system use [10,25]. The average number of VHA 
outpatient visits was similar for veterans in each group. Therefore, we do not believe the 
difference in wound outcomes is attributable to less frequent care among dual users.  
There are several limitations to this study. The first relates to differences between our 
data sources. As described by Burgess et al., the purpose of an administrative dataset 
influences the information contained in that dataset and its utility in research [35]. In this study, 
we relied heavily on VHA data and did not include wound care paid for through sources other 
than VHA and Medicare, which may have underrepresented utilization and complexity across 
systems [11,36]​ ​and could have biased our results. Also, this sample was limited to veterans 
who used VHA for at least one follow-up wound care visit. Therefore, these results are not 
representative of veterans who use VHA with very low frequency and did not include veterans 
who receive all of their wound care outside of VHA, including Medicare-exclusive users. This 
sampling approach may explain why a smaller proportion of veterans included in our study 
were dual users (18%) compared to other studies (as high as 50%) [2–4]. The interpretation of 
our findings is limited somewhat by the small number of dual wound care users and the 
resulting imprecision in estimates related to amputation and death. Also, some covariates 
remained poorly balanced after propensity score or IPTW weighting, which could have resulted 
in residual confounding. Finally, the data used in this study are from 2006-2008 and it is 
possible that practice within VA and Medicare could have changed since they were collected, 
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though we are not aware of any systematic efforts to improve wound care or coordination 
across VHA and Medicare since the study period.  
Our findings have potential implications for the organization of wound care within VHA. 
Previous studies have demonstrated that highly coordinated care and regular follow-up are 
important for reducing amputations and speeding wound healing [14,16]. If single-system use is 
better for veterans, VHA may need to consider designing programs or policies that support 
exclusive VHA utilization for chronic wound care. VHA’s Patient-Aligned Care Teams (PACT), the 
patient-centered medical home program that involves team-based and coordinated care 
[37,38], might be tailored to deliver high quality wound care, for example [39]. Future research 
should examine whether specific elements of PACT, including those related to coordinated 
care, are associated with improved wound healing [40]. Additional work is needed to replicate 
our findings and to establish more precise estimates. Also, additional research is needed to 
understand why dual use results in poorer health outcomes and to identify patient and 
system-level factors not measured in this study – such as patient adherence, provider 
communication, quality of care, and cross-system coordination – that may explain the observed 
difference in wound healing for dual users. These factors may be useful targets for 
interventions to reduce the negative outcomes associated with dual use. 
  
18 
 
Acknowledgements 
This research was funded by the Department of Veterans Affairs Health Services Research & 
Development, IBA 09-061. Support for VA/CMS  data is provided by the Department of 
Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health 
Services Research and Development, VA Information Resource Center (Project Numbers SDR 
02-237 and 98-004). Dr. Reiber was supported by a Senior VA Career Scientist Award (RCS 
98-353). Dr. Littman’s time was supported by a Rehabilitation Research & Development Career 
Development Award (#6982). Dr. Wong was supported by a VA HSR&D Career Development 
Award (CDA 13-024).  
 
Dr. Wong reports ownership of common stock in UnitedHealth Group Inc., Community Health 
Systems Inc. and Quorum Health Corp.​ ​The authors have no other potential conflicts of interest 
to disclose.  
19 
 
List of Abbreviations 
VHA Veterans Health Affairs 
LL Lower limb 
HR Hazard ratio 
SCD Service connected disability 
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Tables 
Table 1. Baseline demographic, health, and wound characteristics of veterans with chronic 
lower limb (LL) wounds and area level health supply characteristics by Medicare-VHA dual 
wound care use in overall sample and in samples weighted by propensity score and inverse 
probability of treatment weights. 
Variable Category 
Original sample 
PS-weighted sample 
Medicare-
VHA dual 
users 
(n=41) 
VHA-excl
usive 
users 
(n=186) 
Standard-i
zed 
difference 
Medicare-
VHA dual 
users 
(n=41) 
VHA-excl
usive 
users 
(n=186) 
Standard-i
zed 
difference 
% %  % %  
Age (years) ≥65  63.4 67.2 0.07 65 61 0.09 
Gender Male 95.1 98.9 0.23 94 98 0.23 
Marital 
status 
Married 43.9 54.8 0.28 34 48 0.28 
Race/ 
ethnicity 
White 92.7 91.9 0.01 83 97 0.50 
Black 7.3 3.8 0.17 17 3 0.58 
Asian 0 1.1 0.21 0 0 0 
Native 
American/ 
Alaska Native 
0 0.5 0.15 0 0 0 
Hispanic 0 0.5 0.10 0 0 0 
Other 0 2.1 0.10 0 0 0 
Rural 
residence 
Yes 53.7 53.2 0.04 55 52 0.05 
Service-co
nnected 
disability 
50-100% 34.1 32.8 0.01 35 32 0.06 
Original 
reason for 
Medicare 
eligibility 
Disability 
before age 65 
61.0 50.5 0.17 63 59 0.09 
Health 
conditions  
Diabetes 61.0 58.1 0.02 60 56 0.08 
Diabetes 
complication 
43.9 49.5 0.17 36 49 0.25 
Peripheral 
artery disease 
53.7 53.2  0.04 59 52 0.14 
Cancer 17.1 14.5 0.09 16 15 0.02 
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Cerebrovascul
ar disease 
19.5 21.5 0.02 21 23 0.05 
Congestive 
heart failure 
21.9 28.5 0.19 26 29 0.08 
Connective 
tissue disease 
4.9 4.3 0.04 2 4 0.07 
Coronary 
artery disease 
46.3 41.9 0.08 45 39 0.12 
Hypertension 78.0 84.4 0.19 83 83 0.02 
HIV/AIDS 0 0 -- 0 0 -- 
Liver disease 0 3.2 0.26 0 3 0.27 
Lower limb 
paralysis 
14.6 5.9 0.31 17 8 0.28 
Myocardial 
infarction 
26.8 16.1 0.23 25 16 0.23 
Renal disease 19.5 29.0 0.33 15 27 0.29 
Comorbidity 
score, mean  
4.0 4.1 0.07 4.1 4.0 0.002 
LL history Prior LL wound 58.5 58.6 0.008 54 60 0.13 
Prior LL 
amputation 
19.5 26.9 0.21 11 24 0.30 
Wound 
etiology 
 
Arterial  29.3 16.1 0.29 31 27 0.11 
Diabetic  21.9 29.6 0.21 11 27 0.36 
Neuropathic 4.9 2.7 0.13 9 3 0.28 
Venous 14.6 24.2 0.22 9 18 0.21 
Pressure 14.6 9.1 0.19 16 14 0.07 
Infectious 4.9 8.1 0.12 2 6 0.19 
Other 4.9 7.0 0.08 6 5 0.05 
Mixed​± 4.9 3.2 0.09 15 0 0.77 
Baseline 
wound 
character-i
stics 
Complex 
anatomy at 
wound site§ 
21.9 32.8 0.22 17 25 0.17 
Exposed bone, 
tendon, or 
joint or 
osteomyelitis 
9.7 8.1 0.08 10 10 0.008 
Total 
non-federa
l patient 
care 
Mean (SD) 1.9 1.9 0.01 1.9 1.9 0.03 
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physicians 
per 1,000 
population 
Number of 
hospital 
beds 
available 
per 1,000 
population 
Mean 2.3 2.4 0.04 2.5 2.3 0.10 
Distance to 
nearest 
VHA facility 
(miles) 
Mean 12.3  15.8  0.21 10.4 13.2 0.17 
VHA: Veterans Health Administration 
PS: Propensity score 
IPTW: Inverse probability of treatment weight 
§Complex anatomy includes Charcot foot, hammer toe, or previous amputation at wound site 
±Mixed etiology includes any wounds that could not clearly be defined by one of the categories 
listed but instead had features of two different underlying conditions, such as arterial disease 
and diabetes. 
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Table 2. Adjusted competing risks proportional hazards regression results for wound healing, 
amputation, and death in models adjusted for estimated propensity scores​§​ and weighted using 
inverse probability of treatment weights​±​ among Veterans with chronic lower limb wounds.  
Wound care 
use 
Primary Outcome Competing Risks 
Wound healed 
(n=165 events) 
Wound amputated 
(n=17 events) 
Veteran died with wound 
(n=17 events) 
Hazard Ratio 
(95% CI) 
p-value 
Hazard Ratio 
(95% CI) 
p-value 
Hazard Ratio 
(95% CI) 
p-value 
Propensity Score Models​§ 
VHA-exclusive 
(n=186 
veterans) 
Reference Reference Reference 
Dual use  
(n=41 veterans) 
 
0.63 
(0.39-0.99) 
 
0.047 
 
4.23  
(1.61-11.15) 
 
0.003 
 
3.08 
(1.11-8.56) 
 
0.031 
Inverse Probability Weight Models​± 
VHA-exclusive 
(n=186 
veterans) 
Reference Reference Reference 
Dual use  
(n=41 veterans) 
0.65 
(0.39-1.06) 
0.081 
4.04 
(1.16-14.09) 
0.028 
2.88 
(0.80-10.29) 
0.10 
§​Propensity score models included estimated propensity score and propensity score squared. 
Propensity scores were estimated from a logistic regression model including age, white race 
and non-Hispanic ethnicity, black race and non-Hispanic ethnicity, married, service connected 
disability ≥50%, prior lower limb wound, prior lower limb amputation, complex anatomy at 
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wound site, baseline wound severity (exposed bone, joint, or tendon), an interaction between 
comorbidity score and wound etiology, and interactions between rural residence and three 
health care supply variables (total non-federal patient care MDs per 1,000 population in zip 
code, total hospital beds per 1,000 population in zip code, and distance to nearest VA). 
±​Inverse probability weights were calculated using the propensity score calculated as described 
for the propensity score-adjusted models. 
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Figure 1. Cumulative incidence of chronic lower limb wound healing among veterans who used 
both VHA and Medicare (dual users) and those who used VHA exclusively in VISN 20 from 
October 1, 2006-September 30, 2007 based on a competing risks proportional hazards model​± 
using a time-varying classification of dual use. 
 
±​Adjusted for: estimated propensity score and propensity score squared. Propensity scores 
were estimated from a logistic regression model including age, white race and non-Hispanic 
ethnicity, black race and non-Hispanic ethnicity, married, service connected disability ≥50%, 
prior lower limb wound, prior lower limb amputation, complex anatomy at wound site, baseline 
wound severity (exposed bone, joint, or tendon), an interaction between comorbidity score and 
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wound etiology, and interactions between rural residence and three health care supply 
variables (total non-federal patient care MDs per 1,000 population in zip code, total hospital 
beds per 1,000 population in zip code, and distance to nearest VHA). 
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